HealthCap

HealthCap is a European life sciences venture capital firm founded in 1996 with offices in Stockholm, London and Zurich that focuses on early-stage, growth and late-stage investments in biotechnology and medical technology companies developing therapeutics, diagnostics and platform technologies. The firm invests across the innovation lifecycle—from seed through later rounds—partnering with scientific founders and management teams to advance promising biomedical research toward clinical development and commercialization. HealthCap deploys capital alongside strategic, regulatory and operational guidance informed by deep sector expertise to help portfolio companies navigate complex drug and device development pathways. Its investment strategy emphasizes rigorous scientific validation, strong intellectual property positions and large addressable markets in areas such as oncology, immunology, rare diseases and chronic conditions. HealthCap’s portfolio spans multiple countries and has supported numerous companies through significant clinical and corporate milestones.